| Jcurve Solutions Ltd (JCS) ORDINARY FULLY PAID |
Information Technology |
$13 |
Cleansing Notice under Section 708A(5)(e) of Corps Act
|
14 Aug 2025 9:50AM |
$0.042 |
$0.036 |
fallen by
14.29%
|
|
| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$637 |
July Investment Update
|
14 Aug 2025 9:50AM |
$3.330 |
$2.780 |
fallen by
16.52%
|
|
| Jcurve Solutions Ltd (JCS) ORDINARY FULLY PAID |
Information Technology |
$13 |
Application for quotation of securities - JCS
|
14 Aug 2025 9:48AM |
$0.042 |
$0.036 |
fallen by
14.29%
|
|
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$130 |
Pause in Trading
|
14 Aug 2025 9:48AM |
$0.042 |
$0.056 |
risen by
33.33%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Lake Resources NL requested a trading pause for its securities.
- The pause is due to a pending announcement related to a proposed capital raising.
- Trading pause commenced on 14 June 2024.
- Pause will remain until the earlier of normal trading on 18 June 2024 or the announcement release.
- Pause is in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BMG Resources Limited (BMG) ORDINARY FULLY PAID |
Materials |
- |
Application for quotation of securities - BMG
|
14 Aug 2025 9:47AM |
$0.010 |
$0.035 |
risen by
268.42%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$16,880 |
PME FY2025 results presentation
|
14 Aug 2025 9:45AM |
$297.150 |
$161.580 |
fallen by
45.62%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 31.9% to $213 million.
- Profit after tax rose by 39.2% to $115.2 million.
- Underlying EBIT up by 40.5%, reaching $157.7 million.
- EBIT margins at 74%.
- Cash and investments increased by 35.5% to $210.7 million.
- Signed seven new contracts totaling AUD $520 million.
- Two large contract renewals valued at AUD $130 million.
- Completed seven cloud-based implementations.
- Research collaboration agreement with UCSF.
- Expanded operations in other medical specialties and AI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$16,880 |
PME FY2025 results presentation
|
14 Aug 2025 9:45AM |
$297.150 |
$161.580 |
fallen by
45.62%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $213.0M, up 31.9%
- Profit after tax increased by 39.2% to $115.2M
- Underlying EBIT reached $157.7M with 74.0% margins
- Seven new contracts totaling AUD $520M
- Two large contract renewals worth AUD $130M
- Completed seven cloud-based implementations
- Signed research collaboration agreement with UCSF
- Focus on imaging and AI expansion
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$606 |
Management's Discussion & Analysis (30 June 2025)
|
14 Aug 2025 9:45AM |
$3.590 |
$7.230 |
risen by
101.39%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Review of financial and operational highlights for the six months ending 30 June 2025.
- Discussion of gold production, revenue generation, and changes in cost structures.
- Updates on ongoing mining projects and exploration initiatives.
- Analysis of operating expenses and efforts to improve efficiency.
- Assessment of risks, including market fluctuations, regulatory concerns, and operational hazards.
- Focus on maintaining sustainable growth and delivering shareholder value.
- Emphasis on responsible financial management amid industry uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Capital Limited (WAM) ORDINARY FULLY PAID |
Financials |
$1,696 |
Dividend/Distribution - WAM
|
14 Aug 2025 9:45AM |
$1.705 |
$1.490 |
fallen by
12.61%
|
|
WAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Dividend distribution amount is AUD 0.0775 per security.
- 60% of the dividend is franked with a 30% corporate tax rate.
- Ex-dividend date: October 20, 2025.
- Record date: October 21, 2025.
- Payment date: October 31, 2025.
- DRP is fully applicable with no discount.
- Deadline for DRP election is October 23, 2025.
- DRP price calculation based on VWAP from ex-date and next three days.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Capital Limited (WAM) ORDINARY FULLY PAID |
Financials |
$1,696 |
Dividend/Distribution - WAM
|
14 Aug 2025 9:45AM |
$1.705 |
$1.490 |
fallen by
12.61%
|
|
WAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Dividend distribution of AUD 0.0775 per security.
- Distribution period ending 30 June 2025.
- Ex-date: 20 October 2025.
- Record date: 21 October 2025.
- Payment date: 31 October 2025.
- Franking percentage: 60%.
- Corporate tax rate for franking: 30%.
- Full Dividend Reinvestment Plan available.
- DRP election deadline: 23 October 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$50 |
Application for quotation of securities - MTH
|
14 Aug 2025 9:45AM |
$0.500 |
$0.265 |
fallen by
47%
|
|
| 4DS Memory Limited (4DS) ORDINARY FULLY PAID |
Information Technology |
$23 |
Trading Halt
|
14 Aug 2025 9:45AM |
$0.028 |
$0.011 |
fallen by
60.71%
|
|
4DS - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DS Memory Limited has requested a trading halt on June 14, 2024.
- The trading halt is pending an announcement about a proposed capital raising.
- The halt will last until the announcement is made or trading begins on June 18, 2024.
- The request aims to ensure the market remains fully informed.
- The company is not aware of any reason why the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$234 |
Trading Halt
|
14 Aug 2025 9:45AM |
$1.710 |
$2.080 |
risen by
21.64%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited (ASX: BCN) requested a trading halt effective 18 March 2024.
- The trading halt is due to a pending announcement regarding a material capital raising.
- Securities will remain in a trading halt until the earlier of commencement of normal trading on 20 March 2024 or a capital raising announcement.
- The trading halt was approved by the ASX.
- The company is working to finalize details of the capital raising during the trading halt period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infragreen Group Limited (IFN) ORDINARY FULLY PAID |
Industrials |
$59 |
Full Year Results Briefing
|
14 Aug 2025 9:44AM |
$1.240 |
$0.440 |
fallen by
64.52%
|
|
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$606 |
Interim Consolidated Financial Statements (30 June 2025)
|
14 Aug 2025 9:44AM |
$3.590 |
$7.230 |
risen by
101.39%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Provides interim consolidated financial statements for the six-month period ending June 30, 2025.
- Prepared in compliance with International Financial Reporting Standards (IFRS) and are unaudited.
- Includes detailed financial statements: position, income, changes in equity, and cash flows.
- Discusses significant accounting policies, critical estimates, and key assumptions.
- Features notes on Nampala mine performance, exploration assets, and property, plant, and equipment.
- Details on borrowings, share capital structure, and related party transactions are included.
- Discloses contingent liabilities, commitments, and information on liquidity management.
- Focuses on maintaining continuous operations and adapting to current market conditions.
- Comparative figures from previous periods are provided for analysis.
- Management’s discussion highlights risk management, financial strategy, and operational updates.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$120 |
Response to ASX Cleansing Notice Timing Letter
|
14 Aug 2025 9:44AM |
$0.300 |
$0.490 |
risen by
63.33%
|
|
| BMG Resources Limited (BMG) ORDINARY FULLY PAID |
Materials |
- |
Cleansing notice - Issue of shares for placement
|
14 Aug 2025 9:42AM |
$0.010 |
$0.035 |
risen by
268.42%
|
|
| Raiden Resources Limited (RDN) ORDINARY FULLY PAID |
Materials |
$12 |
Vuzel Update Silver Anomaly Permit & IP Data Processing
|
14 Aug 2025 9:41AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$12 |
Tiros North Assay Results up to 22.4% TiO2
|
14 Aug 2025 9:40AM |
$0.215 |
$0.310 |
risen by
44.19%
|
|
RAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Resouro Strategic Metals Inc reported assay results up to 22.4% TiO2 at Tiros North.
- Initial drilling program used reverse circulation techniques.
- Multiple drill holes demonstrated significant TiO2 grades and rare earth elements.
- The Tiros Project is located in Brazil and is prospective for heavy mineral sands and rare earths.
- Assay results support further exploration and resource development at the site.
- Findings are strategically important due to increasing global demand for titanium and rare earths.
- Company plans additional drilling and metallurgical tests to advance the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freehill Mining Limited (FHS) ORDINARY FULLY PAID |
Materials |
$6 |
Samples grading up to 4.0% Cu from El Dorado exploration
|
14 Aug 2025 9:39AM |
$0.004 |
$0.002 |
fallen by
62.50%
|
|
FHS - Price-sensitive ASX Announcement
Full Release
Key Points
- Freehill Mining Limited (ASX: FHS) conducted exploration at the El Dorado project in Chile.
- Rock chip samples returned grades up to 4.0% copper (Cu).
- Sampling focused on outcrops with visible copper minerals such as malachite and chrysocolla.
- Several new copper targets identified in the southern part of the project area.
- Results confirm high-grade copper mineralisation at surface.
- Company intends to continue systematic exploration, including geophysics and drilling.
- The El Dorado project is a key focus for expanding copper resources.
- These findings align with Freehill Mining's strategy to advance copper exploration in Chile.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Red Mountain Mining Limited (RMX) ORDINARY FULLY PAID |
Materials |
$15 |
Prospectus (Loyalty Options Offer)
|
14 Aug 2025 9:39AM |
$0.008 |
$0.015 |
risen by
81.25%
|
|
RMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Red Mountain Mining Limited (RMX) is offering a pro-rata non-renounceable loyalty options offer to eligible shareholders.
- Eligible shareholders as of 11 June 2021 can receive one Loyalty Option for every three ordinary shares held.
- The Loyalty Options are exercisable at $0.021 on or before 30 June 2023.
- The offer is intended to reward and incentivise long-term shareholders.
- The prospectus provides detailed terms, eligibility criteria, and the timetable for the offer.
- Funds raised from the exercise of options will be used for exploration and working capital.
- The document outlines risks related to the offer and RMX’s business operations.
- RMX’s mineral projects, exploration activities, and future plans are described.
- Directors’ interests, expert consents, and rights of securities are included.
- Participation in the offer involves investment risks consistent with mineral exploration companies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kinetiko Energy Limited (KKO) ORDINARY FULLY PAID |
Energy |
$60 |
Trading Halt
|
14 Aug 2025 9:39AM |
$0.099 |
$0.039 |
fallen by
60.61%
|
|
KKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Kinetiko Energy Limited requested a trading halt on its securities from 5 June 2023.
- The trading halt is pending an announcement regarding a capital raising.
- The halt will remain until 7 June 2023 or until a relevant announcement is released, whichever comes first.
- The request was made pursuant to ASX Listing Rule 17.1.
- The company is not aware of any reason why the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WA1 Resources Ltd (WA1) ORDINARY FULLY PAID |
Materials |
$903 |
Trading Halt
|
14 Aug 2025 9:38AM |
$19.340 |
$12.150 |
fallen by
37.18%
|
|
WA1 - Price-sensitive ASX Announcement
Full Release
Key Points
- WA1 Resources Ltd requested a trading halt effective 5 June 2024.
- The trading halt is related to a pending capital raising announcement.
- The halt will remain until the announcement is made or normal trading resumes on 7 June 2024.
- The request was formally submitted to the ASX.
- The halt is to ensure the orderly release of price-sensitive information.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$16,880 |
CEO Interview FY25 Results
|
14 Aug 2025 9:37AM |
$297.150 |
$161.580 |
fallen by
45.62%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Pro Medicus had a record year with strong financial growth and secured seven new contracts valued at a minimum of AUD $520M.
- The majority of new contract revenue is expected to be realized in FY26, with forward contracted revenue for the next 5 years at AUD $948M.
- Cloud solutions are preferred by Pro Medicus clients for scalability, security, and cost-effectiveness, with a fully cloud-based offering unlike competitors' hybrid solutions.
- Pro Medicus is advancing in AI with collaborations and licensing agreements, notably for breast cancer detection and plaque algorithms.
- The company holds 10% of the North American market share, with significant growth potential due to its cloud-based platform and efficient implementation process.
- Cardiology is a critical component of contracts, enhancing the total value for clients, with plans to integrate other medical 'ologies'.
- The company's EBIT margins increased to 74%, with further growth potential from new contracts.
- Pro Medicus focuses on premium pricing, providing high ROI both financially and clinically.
- The company has over $210 million in cash reserves for growth investment, dividends, and potential acquisitions.
- Pro Medicus has a strong renewal record, with key contracts extended at higher fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$16,880 |
CEO Interview FY25 Results
|
14 Aug 2025 9:37AM |
$297.150 |
$161.580 |
fallen by
45.62%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- Pro Medicus Limited had its strongest financial year in FY25.
- Secured seven new contracts totaling AUD $520 million.
- Cloud solutions are a strategic focus for scalability and security.
- Unique 100% cloud-based offering distinguishes Pro Medicus from competitors.
- AI advancements include collaborations with UCSF and NYU Langone.
- Cardiology and pathology integrations in Visage 7 platform.
- Maintained a 100% renewal rate for existing contracts.
- Forward contracted revenue expected to reach AUD $948 million in five years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
